Jim’s crystal balls are still on shaky ground. The old rules seem to no longer apply. We’re trying to go down a different path.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025